Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
---|
47781-0340 | Acarbose | Alvogen, Inc. | YES | 2021-12-31 |
47781-0341 | Acarbose | Alvogen, Inc. | YES | 2021-12-31 |
47781-0342 | Acarbose | Alvogen, Inc. | YES | 2021-12-31 |
47781-0447 | Azelaic Acid | Alvogen, Inc. | YES | No later than 2018-06-28 |
47781-0270 | Bosentan | Alvogen Inc. | YES | No later than 2022-06-28 |
47781-0271 | Bosentan | Alvogen Inc. | YES | No later than 2022-06-28 |
47781-0146 | Budesonide (enteric coated) | Alvogen, Inc. | YES | 2019-08-31 |
47781-0355 | Buprenorphine and Naloxone Sublingual Film | Alvogen Inc. | NO | |
47781-0356 | Buprenorphine and Naloxone Sublingual Film | Alvogen Inc. | NO | |
47781-0357 | Buprenorphine and Naloxone Sublingual Film | Alvogen Inc. | NO | |
47781-0358 | Buprenorphine and Naloxone Sublingual Film | Alvogen Inc. | NO | |
47781-0406 | buprenorphine transdermal system | Alvogen Inc. | NO | |
47781-0407 | buprenorphine transdermal system | Alvogen Inc. | NO | |
47781-0408 | buprenorphine transdermal system | Alvogen Inc. | NO | |
47781-0419 | buprenorphine transdermal system | Alvogen Inc. | NO | |
47781-0637 | bupropion hydrochloride | Alvogen Inc. | YES | 2026-03-01 |
47781-0534 | butalbital and acetaminophen | Alvogen Inc. | YES | 2020-09-01 |
47781-0535 | Butalbital and Acetaminophen | Alvogen, Inc. | YES | 2020-05-01 |
47781-0628 | Butalbital and Acetaminophen | Alvogen, Inc. | YES | 2022-11-01 |
47781-0644 | butalbital and acetaminophen | Alvogen Inc. | YES | 2022-09-01 |
47781-0536 | Butalbital, Acetaminophen, and Caffeine | Alvogen Inc. | YES | No later than 2020-04-01 |
47781-0625 | Butalbital, Acetaminophen, and Caffeine | Alvogen Inc. | YES | 2022-08-01 |
47781-0332 | Carbidopa Tablets, 25 mg | Alvogen Inc. | NO | |
47781-0603 | CARBOPLATIN | Alvogen Inc. | YES | 2019-09-01 |
47781-0604 | CARBOPLATIN | Alvogen Inc. | YES | 2019-09-01 |
47781-0605 | CARBOPLATIN | Alvogen Inc. | YES | 2019-09-01 |
47781-0606 | CARBOPLATIN | Alvogen Inc. | YES | 2019-09-01 |
47781-0613 | Caspofungin Acetate | Alvogen Inc. | YES | 2021-10-01 |
47781-0614 | Caspofungin Acetate | Alvogen Inc. | YES | 2021-10-01 |
47781-0266 | Cefaclor | Alvogen, Inc. | YES | No later than 2019-03-18 |
47781-0267 | Cefaclor | Alvogen, Inc. | YES | No later than 2019-03-18 |
47781-0530 | Ciclopirox | Alvogen Inc. | YES | 2021-09-01 |
47781-0609 | Cisplatin | Alvogen Inc. | YES | 2020-03-01 |
47781-0610 | Cisplatin | Alvogen Inc. | YES | 2020-03-01 |
47781-0459 | Clindamycin | Alvogen Inc. | YES | 2020-06-01 |
47781-0460 | Clindamycin | Alvogen Inc. | YES | 2020-05-01 |
47781-0461 | Clindamycin | Alvogen Inc. | YES | No later than 2020-04-01 |
47781-0462 | Clindamycin | Alvogen Inc. | YES | No later than 2019-12-28 |
47781-0463 | Clindamycin | Alvogen Inc. | YES | No later than 2019-12-28 |
47781-0464 | Clindamycin | Alvogen Inc. | YES | No later than 2019-12-28 |
47781-0465 | Clindamycin | Alvogen Inc. | YES | 2020-04-01 |
47781-0619 | Clindamycin Phosphate | Alvogen, Inc. | YES | 2019-12-31 |
47781-0620 | Clindamycin Phosphate | Alvogen, Inc. | YES | 2019-12-31 |
47781-0621 | Clindamycin Phosphate | Alvogen, Inc. | YES | 2019-12-31 |
47781-0333 | Dapsone | Alvogen Inc. | YES | No later than 2021-09-22 |
47781-0334 | Dapsone | Alvogen Inc. | YES | No later than 2021-09-22 |
47781-0623 | Deferoxamine mesylate | Alvogen Inc. | YES | No later than 2020-12-31 |
47781-0624 | Deferoxamine mesylate | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0914 | Dexamethasone | Alvogen Inc. | NO | |
47781-0916 | Dexamethasone | Alvogen Inc. | NO | |
47781-0578 | Dexrazoxane | Alvogen Inc. | YES | 2021-12-01 |
47781-0174 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | NO | |
47781-0175 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | YES | No later than 2019-10-01 |
47781-0176 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | NO | |
47781-0177 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | YES | No later than 2019-10-01 |
47781-0178 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | NO | |
47781-0179 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | NO | |
47781-0180 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | Alvogen Inc. | NO | |
47781-0607 | Disulfiram | Alvogen Inc. | NO | |
47781-0216 | Donepezil Hydrochloride | ALVOGEN | YES | No later than 2014-09-24 |
47781-0217 | Donepezil Hydrochloride | ALVOGEN | YES | No later than 2014-09-24 |
47781-0135 | Dorzolamide Hydrochloride Ophthalmic Solution 2%, 10mL Ophthalmic Solution 2%, 10mL | ALVOGEN INC. | YES | No later than 2019-03-18 |
47781-0136 | Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution Sterile Ophthalmic Solution | ALVOGEN INC. | YES | No later than 2019-03-18 |
47781-0256 | Doxorubicin Hydrochloride | Alvogen Inc. | YES | No later than 2018-10-01 |
47781-0489 | Doxycycline Hyclate | Alvogen, Inc. | YES | 2021-05-01 |
47781-0490 | Doxycycline Hyclate | Alvogen, Inc. | YES | 2021-10-01 |
47781-0491 | Doxycycline Hyclate | Alvogen, Inc. | YES | 2023-05-01 |
47781-0543 | Econazole Nitrate Cream | Alvogen Inc. | YES | No later than 2019-10-01 |
47781-0104 | Estradiol | Alvogen Inc. | NO | |
47781-0204 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2021-06-01 |
47781-0205 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2020-12-01 |
47781-0206 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2021-03-01 |
47781-0207 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2020-12-01 |
47781-0208 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2021-04-01 |
47781-0209 | Estradiol Transdermal System | Alvogen, Inc. | YES | 2021-05-01 |
47781-0497 | Ethacrynic acid | Alvogen, Inc. | YES | 2022-01-01 |
47781-0108 | Exemestane | Alvogen Inc. | YES | No later than 2022-12-30 |
47781-0550 | Felbamate | Alvogen Inc. | YES | 2020-07-01 |
47781-0551 | Felbamate | Alvogen Inc. | YES | 2020-09-01 |
47781-0627 | Felbamate | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0630 | Felbamate | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0518 | Fenofibrate | Alvogen Inc. | YES | No later than 2019-03-18 |
47781-0519 | Fenofibrate | Alvogen Inc. | YES | No later than 2019-03-18 |
47781-0520 | Fenofibrate | Alvogen Inc. | YES | No later than 2019-03-18 |
47781-0423 | Fentanyl system | ALVOGEN | NO | |
47781-0424 | Fentanyl system | ALVOGEN | NO | |
47781-0426 | Fentanyl system | ALVOGEN | NO | |
47781-0427 | Fentanyl system | ALVOGEN | NO | |
47781-0428 | Fentanyl system | ALVOGEN | NO | |
47781-0569 | Fluocinonide | Alvogen Inc. | YES | 2024-11-01 |
47781-0602 | Fluocinonide | Alvogen Inc. | YES | No later than 2023-12-19 |
47781-0532 | Fluocinonide Cream (Emulsified Base) | Alvogen Inc. | YES | 2021-06-01 |
47781-0533 | Fluocinonide Gel | Alvogen Inc. | YES | 2024-05-01 |
47781-0600 | Fluoxetine Hydrochloride | Alvogen Inc. | YES | 2024-07-01 |
47781-0147 | Gadopentetate dimeglumine | Alvogen, Inc | YES | No later than 2019-12-28 |
47781-0392 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0393 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0394 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0395 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0396 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0397 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0398 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0409 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0410 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0411 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0412 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0413 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0414 | Hydrocodone Bitartrate | Alvogen Inc. | NO | |
47781-0444 | Hydrocodone Bitartrate and Acetaminophen | Alvogen Inc. | YES | 2021-12-31 |
47781-0445 | Hydrocodone Bitartrate and Acetaminophen | Alvogen Inc. | YES | 2021-12-31 |
47781-0446 | Hydrocodone Bitartrate and Acetaminophen | Alvogen Inc. | YES | 2021-12-31 |
47781-0452 | Hydrocodone Bitartrate and Acetaminophen | Alvogen, Inc. | YES | 2021-12-31 |
47781-0453 | Hydrocodone Bitartrate and Acetaminophen | Alvogen, Inc. | YES | 2021-12-31 |
47781-0454 | Hydrocodone Bitartrate and Acetaminophen | Alvogen, Inc. | YES | 2021-12-31 |
47781-0455 | Hydrocodone Bitartrate and Acetaminophen | Alvogen, Inc. | YES | 2021-12-31 |
47781-0011 | Hyoscyamine Sulfate | Alvogen Inc. | YES | 2025-12-01 |
47781-0012 | Hyoscyamine Sulfate | Alvogen Inc. | YES | 2025-09-01 |
47781-0013 | hyoscyamine sulfate | Alvogen Inc. | YES | 2025-11-01 |
47781-0014 | hyoscyamine sulfate | Alvogen Inc. | YES | 2025-09-01 |
47781-0103 | IBANDRONATE SODIUM | Alvogen Inc. | NO | |
47781-0275 | Isosorbide Mononitrate Extended Release | Alvogen, Inc. | YES | No later than 2014-09-24 |
47781-0583 | Ketorolac Tromethamine | Alvogen Inc. | YES | 2021-11-01 |
47781-0584 | Ketorolac Tromethamine | Alvogen Inc. | YES | 2021-11-01 |
47781-0585 | Ketorolac Tromethamine | Alvogen Inc. | YES | 2021-11-01 |
47781-0552 | Labetalol Hydrochloride | Alvogen Inc. | YES | No later than 2023-08-03 |
47781-0553 | Labetalol Hydrochloride | Alvogen Inc. | YES | 2023-11-01 |
47781-0554 | Labetalol Hydrochloride | Alvogen Inc. | YES | 2023-10-01 |
47781-0586 | Labetalol Hydrochloride | Alvogen Inc. | YES | 2025-03-01 |
47781-0483 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0484 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0485 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0486 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0487 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0488 | LENALIDOMIDE | Alvogen, Inc. | NO | |
47781-0640 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0643 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0646 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0649 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0651 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0654 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0657 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0659 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0662 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0665 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0668 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0671 | levothyroxine sodium | Alvogen, Inc. | NO | |
47781-0570 | Lidocaine | Alvogen Inc. | YES | 2022-09-01 |
47781-0571 | Lidocaine | Alvogen Inc. | YES | 2022-11-01 |
47781-0562 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0563 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0564 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0565 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0566 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0567 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0568 | lisdexamfetamine dimesylate | Alvogen Inc. | NO | |
47781-0200 | Melphalan | Alvogen Inc. | YES | 2024-05-01 |
47781-0622 | Mesna | Alvogen Inc. | YES | No later than 2020-12-31 |
47781-0577 | Methenamine Hippurate | Alvogen Inc. | YES | 2027-11-01 |
47781-0482 | METHOTREXATE | Alvogen Inc. | YES | No later than 2023-12-19 |
47781-0415 | Methylphenidate hydrochloride | Alvogen Inc. | YES | 2022-11-01 |
47781-0416 | Methylphenidate hydrochloride | Alvogen Inc. | YES | 2022-11-01 |
47781-0417 | Methylphenidate hydrochloride | Alvogen Inc. | YES | 2022-11-01 |
47781-0418 | Methylphenidate hydrochloride | Alvogen Inc. | YES | 2022-11-01 |
47781-0537 | Methylphenidate Hydrochloride | Alvogen Inc. | YES | 2018-10-01 |
47781-0538 | Methylphenidate Hydrochloride | Alvogen Inc. | YES | 2018-10-01 |
47781-0539 | Methylphenidate Hydrochloride | Alvogen Inc. | YES | 2018-10-01 |
47781-0540 | METHYLPHENIDATE HYDROCHLORIDE | Alvogen Inc. | YES | No later than 2020-04-01 |
47781-0541 | METHYLPHENIDATE HYDROCHLORIDE | Alvogen Inc. | YES | No later than 2020-04-01 |
47781-0629 | METHYLPHENIDATE HYDROCHLORIDE | Alvogen Inc. | YES | 2023-12-31 |
47781-0631 | METHYLPHENIDATE HYDROCHLORIDE | Alvogen Inc. | YES | 2023-12-31 |
47781-0587 | Metoprolol Tartrate | Alvogen Inc. | YES | 2021-05-01 |
47781-0588 | Midazolam | Alvogen Inc. | YES | 2022-04-01 |
47781-0589 | Midazolam | Alvogen Inc. | YES | 2023-06-01 |
47781-0544 | minocycline hydrochloride | Alvogen, Inc. | YES | 2023-11-01 |
47781-0545 | minocycline hydrochloride | Alvogen, Inc. | YES | 2023-11-01 |
47781-0546 | minocycline hydrochloride | Alvogen, Inc. | YES | 2023-11-01 |
47781-0268 | Moxifloxacin Hydrochloride | Alvogen, Inc. | YES | No later than 2020-07-01 |
47781-0153 | Naproxen Sodium | Alvogen Inc. | NO | |
47781-0154 | Naproxen Sodium | Alvogen Inc. | NO | |
47781-0155 | Naproxen Sodium | Alvogen Inc. | NO | |
47781-0100 | nevirapine | Alvogen Inc. | YES | No later than 2019-03-18 |
47781-0317 | Nevirapine Extended Release | Alvogen Inc. | YES | No later than 2021-12-22 |
47781-0368 | Nifedipine | Alvogen Inc. | YES | 2020-04-01 |
47781-0369 | Nifedipine | Alvogen Inc. | YES | 2020-04-01 |
47781-0370 | Nifedipine | Alvogen Inc. | YES | 2020-04-01 |
47781-0306 | nitrofurantoin macrocrystals | Alvogen Inc. | NO | |
47781-0307 | nitrofurantoin macrocrystals | Alvogen Inc. | NO | |
47781-0308 | nitrofurantoin macrocrystals | Alvogen Inc. | NO | |
47781-0303 | Nitrofurantoin Monohydrate/ Macrocrystalline | Alvogen Inc. | NO | |
47781-0456 | nitroglycerin | Alvogen Inc. | YES | 2024-06-01 |
47781-0457 | nitroglycerin | Alvogen Inc. | YES | 2024-06-01 |
47781-0458 | nitroglycerin | Alvogen Inc. | YES | 2024-06-01 |
47781-0296 | Nitroglycerin Transdermal Delivery System | Alvogen, Inc. | YES | 2021-08-01 |
47781-0297 | Nitroglycerin Transdermal Delivery System | Alvogen, Inc. | YES | 2021-08-01 |
47781-0298 | Nitroglycerin Transdermal Delivery System | Alvogen, Inc. | YES | 2021-11-01 |
47781-0299 | Nitroglycerin Transdermal Delivery System | Alvogen, Inc. | YES | 2021-08-01 |
47781-0137 | Olopatadine Hydrochloride | Alvogen Inc. | YES | No later than 2019-03-18 |
47781-0468 | Oseltamivir Phosphate | Alvogen Inc. | NO | |
47781-0469 | Oseltamivir Phosphate | Alvogen Inc. | NO | |
47781-0470 | Oseltamivir Phosphate | Alvogen Inc. | NO | |
47781-0384 | Oseltamivir Phosphate for Oral Suspension | Alvogen Inc. | NO | |
47781-0591 | Oxaliplatin | Alvogen Inc. | YES | 2019-12-01 |
47781-0592 | Oxaliplatin | Alvogen Inc. | YES | 2019-12-01 |
47781-0196 | Oxycodone and Acetaminophen | Alvogen, Inc. | NO | |
47781-0229 | Oxycodone and Acetaminophen | Alvogen, Inc. | NO | |
47781-0230 | Oxycodone and Acetaminophen | Alvogen, Inc. | NO | |
47781-0263 | Oxycodone hydrochloride | Alvogen, Inc. | NO | |
47781-0264 | Oxycodone hydrochloride | Alvogen, Inc. | NO | |
47781-0265 | Oxycodone hydrochloride | Alvogen, Inc. | NO | |
47781-0593 | Paclitaxel | Alvogen Inc. | YES | 2020-08-01 |
47781-0594 | Paclitaxel | Alvogen Inc. | YES | 2020-01-01 |
47781-0595 | Paclitaxel | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0476 | PARICALCITOL | ALVOGEN, INC. | YES | No later than 2019-12-28 |
47781-0477 | PARICALCITOL | ALVOGEN, INC. | YES | No later than 2019-12-28 |
47781-0478 | PARICALCITOL | ALVOGEN, INC. | YES | No later than 2019-12-28 |
47781-0596 | Polymyxin B | Alvogen Inc. | YES | No later than 2020-12-31 |
47781-0379 | Pregabalin Extended Release | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0380 | Pregabalin Extended Release | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0381 | Pregabalin Extended Release | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0331 | Primaquine Phosphate | Alvogen, Inc. | YES | No later than 2019-03-18 |
47781-0335 | Pyridostigmine Bromide | Alvogen, Inc. | NO | |
47781-0925 | pyrimethamine | Alvogen Inc. | NO | |
47781-0683 | Rasagiline | Alvogen, Inc. | NO | |
47781-0690 | Rasagiline | Alvogen, Inc. | NO | |
47781-0138 | Rasagiline Mesylate | Alvogen, Inc. | YES | 2020-09-01 |
47781-0139 | Rasagiline Mesylate | Alvogen, Inc. | YES | 2020-10-01 |
47781-0304 | Rivastigmine Transdermal System | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0305 | Rivastigmine Transdermal System | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0405 | Rivastigmine Transdermal System | Alvogen Inc. | YES | No later than 2024-12-19 |
47781-0616 | Rocuronium Bromide | Alvogen Inc. | YES | 2021-10-01 |
47781-0617 | Rocuronium Bromide | Alvogen Inc. | YES | 2021-12-01 |
47781-0652 | teriparatide | Alvogen, Inc. | NO | |
47781-0910 | testosterone cypionate | Alvogen Inc. | NO | |
47781-0911 | testosterone cypionate | Alvogen Inc. | NO | |
47781-0508 | Tetracycline Hydrochloride | Alvogen Inc. | YES | 2021-07-01 |
47781-0509 | Tetracycline Hydrochloride | Alvogen Inc. | YES | 2022-04-01 |
47781-0219 | Tramadol Hydrochloride and Acetaminophen | Alvogen, Inc. | YES | No later than 2014-09-24 |
47781-0601 | Tranexamic Acid | Alvogen Inc. | YES | No later than 2021-12-22 |
47781-0517 | Tranylcypromine Sulfate | Alvogen Inc. | YES | 2021-08-01 |
47781-0597 | Vancomycin Hydrochloride | Alvogen Inc. | YES | 2022-04-01 |
47781-0598 | Vancomycin Hydrochloride | Alvogen Inc. | YES | 2022-04-01 |
47781-0729 | vancomycin hydrochloride | Alvogen Inc. | YES | 2025-01-01 |
47781-0730 | vancomycin hydrochloride | Alvogen Inc. | YES | 2024-09-01 |
47781-0466 | VORICONAZOLE | Alvogen Inc. | YES | 2025-04-01 |